Zhenyu Ding

机构：Sichuan University, West China Hospital of Sichuan University

发表论文 17 篇 · 总被引 171 次 · h-index 6

代表论文

• Enantioselective Allylic Amination of Morita–Baylis–Hillman Carbonates Catalysed by Modified Cinchona Alkaloids (2009 · European Journal of Organic Chemistry · 被引 54)
• Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen (2004 · European Journal of Immunology · 被引 40)
• First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial (2025 · Nature Medicine · 被引 20)
• Sacituzumab tirumotecan (SKB264/MK-2870) in combination with KL-A167 (anti-PD-L1) as first-line treatment for patients with advanced NSCLC from the phase II OptiTROP-Lung01 study. (2024 · Journal of Clinical Oncology · 被引 19)
• Antitumour activity of cationic‐liposome‐conjugated adenovirus containing the CCL19 [chemokine (C‐C motif) ligand 19] gene (2007 · Biotechnology and Applied Biochemistry · 被引 10)
• Advancements in elucidating the mechanisms of Sorafenib resistance in hepatocellular carcinoma (2025 · International Journal of Surgery · 被引 7)